SOLUS CARE
Sun Pharma gets CCI nod to sell two CNS divisions to Strides Shasun for Rs 165 croreDrug major Sun Pharma has received approval from competition watchdog CCI to sell the erstwhile Ranbaxy Laboratories' two divisions.
Strides Shasun gets CCI nod to buy Sun Pharma's two divisionsStrides Shasun today got CCI's approval to acquire Sun Pharmaceutical's two business divisions in India for Rs 165 crore.
Strides Arcolab gains as company acquires CNS divisions of erstwhile RanbaxyThe agreement involves transfer of these two marketing divisions, along with employees to Strides for a consideration of Rs 165 crore.
Sun Pharma sells divisions of Ranbaxy to Strides Arcolab for Rs 165 croreAs part of the deal, India’s largest drug maker Sun Pharma will transfer two arms of Ranbaxy – Solus and Solus care – for a consideration o...
Does endorsement from multiple celebrities at the same time help a brand?Can multiple celebrity ambassadors add more sheen to a brand? Or is bringing in a pair of fresh legs just a smart strategy in succession pl...
Load More